Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Clinical trial NCT02722512 · TERMINATED

Trial details

NCT number: NCT02722512
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Astrocytoma, Grade III Anaplastic Ependymoma Clear Cell Ependymoma Ependymoma

Start date: 2016-07-01
Primary completion: 2019-11-13
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.